0001209191-18-053804.txt : 20181003 0001209191-18-053804.hdr.sgml : 20181003 20181003162527 ACCESSION NUMBER: 0001209191-18-053804 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181001 FILED AS OF DATE: 20181003 DATE AS OF CHANGE: 20181003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BARDON CHRISTIANA CENTRAL INDEX KEY: 0001717679 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37718 FILM NUMBER: 181105315 MAIL ADDRESS: STREET 1: 86 SOUTH STREET STREET 2: C/O SPRING BANK PHARMACEUTICALS, INC. CITY: HOPKINTON STATE: MA ZIP: 01748 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Spring Bank Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001566373 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 522386345 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 PARKWOOD DRIVE STREET 2: SUITE 210 CITY: HOPKINTON STATE: MA ZIP: 01748 BUSINESS PHONE: 508-473-5993 X119 MAIL ADDRESS: STREET 1: 35 PARKWOOD DRIVE STREET 2: SUITE 210 CITY: HOPKINTON STATE: MA ZIP: 01748 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-10-01 0 0001566373 Spring Bank Pharmaceuticals, Inc. SBPH 0001717679 BARDON CHRISTIANA C/O SPRING BANK PHARMACEUTICALS, INC. 35 PARKWOOD DRIVE HOPKINTON MA 01748 1 0 1 0 Common Stock 2018-10-01 4 A 0 831 0.00 A 2296 D Common Stock 833839 I By UBS Oncology Impact Fund Common Stock 54824 I By Burrage Capital Healthcare Fund I, LP Pursuant to the Issuer's Non-Employee Director Compensation Policy, the shares on this Form 4 were automatically issued to the Reporting Person, who previously elected to take shares in lieu of cash compensation for services as a director and committee member of the Issuer. The Reporting Person's spouse is the Managing Member of MPM Oncology Impact Management GP LLC, an indirect General Partner of UBS Oncology Impact Fund L.P. ("Oncology Impact Fund"). Dr. Bardon disclaims beneficial ownership of the securities held by Oncology Impact Fund, except to the extent of her or her spouse's pecuniary interest therein, and the inclusion of these securities in the report shall not be deemed an admission of beneficial ownership of the securities for the purposes of Section 16 or for any other purpose. The Reporting Person is the Portfolio Manager of Burrage Capital Healthcare Fund I, L.P. ("Burrage Capital"). Dr. Bardon disclaims beneficial ownership of the securities held by Burrage Capital, except to the extent of her pecuniary interest therein, and the inclusion of these securities in the report shall not be deemed an admission of beneficial ownership of the securities for the purposes of Section 16 or for any other purpose. /s/ Christiana Bardon 2018-10-03